Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Advances in Interventional Cardiology
    • Case Reports in Interventional Cardiology
    • Clinical Dilemmas in Cardiovascular Interventions
    • Contemporary Reviews in Interventional Cardiology
  • Resources
    • Instructions for Authors
      • Accepted Manuscripts
      • Revised Manuscripts
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Circulation:
Cardiovascular Interventions

  • My alerts
  • Sign In
  • Join

  • Home
  • About this Journal
    • Editorial Board
    • General Statistics
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Advances in Interventional Cardiology
    • Case Reports in Interventional Cardiology
    • Clinical Dilemmas in Cardiovascular Interventions
    • Contemporary Reviews in Interventional Cardiology
  • Resources
    • Instructions for Authors
    • → Article Types
    • → General Preparation Instructions
    • → Research Guidelines
    • → How to Submit a Manuscript
    • Journal Policies
    • Permissions and Rights Q&A
    • Submission Sites
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Genomic and Precision Medicine
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Images and Case Reports in Interventional Cardiology

Renal Artery Stent Fracture in Patients With Fibromuscular Dysplasia

A Cautionary Tale

Manjunath G. Raju, Christopher T. Bajzer, Daniel G. Clair, Esther S.H. Kim, Heather L. Gornik
Download PDF
https://doi.org/10.1161/CIRCINTERVENTIONS.113.000193
Circulation: Cardiovascular Interventions. 2013;6:e30-e31
Originally published June 18, 2013
Manjunath G. Raju
From the Departments of Cardiovascular Medicine and Vascular Surgery, Cleveland Clinic Foundation, Cleveland, OH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christopher T. Bajzer
From the Departments of Cardiovascular Medicine and Vascular Surgery, Cleveland Clinic Foundation, Cleveland, OH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daniel G. Clair
From the Departments of Cardiovascular Medicine and Vascular Surgery, Cleveland Clinic Foundation, Cleveland, OH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Esther S.H. Kim
From the Departments of Cardiovascular Medicine and Vascular Surgery, Cleveland Clinic Foundation, Cleveland, OH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heather L. Gornik
From the Departments of Cardiovascular Medicine and Vascular Surgery, Cleveland Clinic Foundation, Cleveland, OH.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics

Jump to

  • Article
    • Introduction
    • Patient 1
    • Patient 2
    • Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics
  • eLetters
Loading
  • angiography
  • fibromuscular dysplasia
  • renal artery stenosis
  • stent fracture

Introduction

Fibromuscular dysplasia (FMD) is a nonatherosclerotic vascular disease that most commonly affects the renal, carotid, and vertebral arteries.1 Renal FMD is associated with renovascular hypertension, and patients may be referred for revascularization, generally with balloon angioplasty. We report a series of 2 patients with renal artery FMD who developed stent fracture.

Patient 1

A 16-year-old girl was seen for a second opinion on renal FMD. Hypertension was diagnosed at the age of 13 years and initially treated medically; however, bilateral renal artery angioplasty was subsequently performed for poorly controlled blood pressure. She subsequently underwent placement of a drug eluting stent in the right renal artery for restenosis. Although she initially improved, there was gradual worsening of her blood pressure control. Noninvasive testing was consistent with severe restenosis of the right renal artery stent. Renal arteriography revealed a severe stenosis estimated at 80% in the right renal artery (Figure 1). There was severe narrowing noted at the ostium, resulting in a 70 mm Hg gradient across the lesion. Intravascular ultrasound confirmed stent fracture as the cause of narrowing (Figure 2). The patient was referred for aorto-renal bypass grafting with venous conduit and did well postoperatively.

Figure 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1.

Patient 1: digital subtraction arteriography of the right renal artery in a 16-year-old patient with uncontrolled hypertension who previously underwent angioplasty and stent placement for renal FMD. A, Four-millimeter drug eluting stent in the right renal artery with severe stenosis estimated at 80%.

Figure 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 2.

Patient 1: intravascular ultrasound imaging. A, Severe narrowing noted at the ostium of the stent within the right renal artery. The stent is significantly deformed and narrowed. B, Arrow demonstrates an area of likely stent fracture.

Patient 2

A 41-year-old woman was seen for a second opinion on renal FMD and multidrug-resistant hypertension. She developed hypertension at the age of 30 years, requiring multiple medications. Because of poor blood pressure control, she ultimately underwent angiography, which demonstrated medial fibroplasia for which angioplasty with overlapping stent placement was performed (Figure 3). Blood pressure improved initially, but gradually worsened during the following year with recordings as high as 220/130 mm Hg on 6 medications. Duplex ultrasound revealed markedly elevated velocities within the right renal artery. Selective right renal angiography demonstrated 2 areas of significant narrowing and deformity of the stents (online-only Data Supplement). Intravascular ultrasound confirmed these findings and a likely stent fracture in the middle and distal segments of the stents (Figure 4). The patient underwent aorto-renal bypass grafting with venous conduit with improved control of her blood pressure, although she required subsequent endovascular procedures for bypass graft restenosis.

Figure 3.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 3.

Patient 2: Digital subtraction arteriography performed at an outside institution in a 41-year-old woman with single kidney after prior kidney donation to her sister. Classic medial fibroplasia (string of beads) across a long segment of the main right renal artery was demonstrated before multiple interventional procedures were performed.

Figure 4.
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 4.

Patient 2: intravascular ultrasound imaging. A, The distal renal artery stent well opposed to the vessel wall has been demonstrated. B, In-stent restenosis and area of stent fracture (arrow) in the right renal artery at the area of physiodynamic compression are shown.

Discussion

We report on 2 patients with renal FMD who developed complications of renal artery stenting, namely restenosis and stent fracture, ultimately requiring surgery. Both patients had long segment renal artery stents placed and had marked right renal artery mobility as contributing factors to restenosis and stent fracture.

The renal arteries are frequently involved in FMD, affecting ≈80% of FMD patients who undergo renal imaging studies.1 Renovascular hypertension related to FMD is common, and treatment of hypertension with balloon angioplasty may be effective in curing or better controlling blood pressure in select patients.2 Anecdotal case reports have reported stent fracture because of the compression of the renal artery by musculotendinous fibers originating from the diaphragm.3 Another contributing factor is significant mobility of the kidney (nephroptosis). Although this can occur in all patients, severe nephroptosis has been shown to be more common among patients with renal FMD.4 Increased kinetic stress applied over the stent struts may lead to both reactionary intimal hyperplasia and metal fatigue resulting in-stent restenosis and fracture.

Balloon angioplasty remains the mainstay of endovascular therapy for renal FMD, in contrast to severe atherosclerotic renal artery stenosis for which stenting has become the standard approach. For patients with renal FMD, stenting is generally reserved for cases in which angioplasty has failed or when required to manage renal artery dissection. If renal artery stenting is required, the potential for nephroptosis with subsequent mechanical stress on the stent should be considered in determining revascularization approach. Long areas of stenting should generally be avoided. Surgical revascularization remains a viable therapeutic option for patients with renal FMD with extensive disease not amenable to angioplasty.

Disclosures

Dr Gornik is a volunteer member of the medical advisory board of Fibromuscular Dysplasia Society of America, a nonprofit organization. The other authors have no conflict to report.

Footnotes

  • The online-only Data Supplement is available at http://circinterventions.ahajournals.org/lookup/suppl/doi:10.1161/CIRCINTERVENTIONS.113.000193/-/DC1.

  • Received January 22, 2013.
  • Accepted March 29, 2013.
  • © 2013 American Heart Association, Inc.

References

  1. 1.↵
    1. Olin JW,
    2. Froehlich J,
    3. Gu X,
    4. Bacharach JM,
    5. Eagle K,
    6. Gray BH,
    7. Jaff MR,
    8. Kim ES,
    9. Mace P,
    10. Matsumoto AH,
    11. McBane RD,
    12. Kline-Rogers E,
    13. White CJ,
    14. Gornik HL
    . The United States Registry for Fibromuscular Dysplasia: results in the first 447 patients. Circulation. 2012;125:3182–3190.
    OpenUrlAbstract/FREE Full Text
  2. 2.↵
    1. Trinquart L,
    2. Mounier-Vehier C,
    3. Sapoval M,
    4. Gagnon N,
    5. Plouin PF
    . Efficacy of revascularization for renal artery stenosis caused by fibromuscular dysplasia: a systematic review and meta-analysis. Hypertension. 2010;56:525–532.
    OpenUrlCrossRef
  3. 3.↵
    1. Baguet JP,
    2. Thony F,
    3. Sessa C,
    4. Mallion JM
    . Stenting of a renal artery compressed by the diaphragm. J Hum Hypertens. 2003;17:213–214.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. de Zeeuw D,
    2. Donker AJ,
    3. Burema J,
    4. van der Hem GK,
    5. Mandema E
    . Nephroptosis and hypertension. Lancet. 1977;1:213–215.
    OpenUrlPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Circulation: Cardiovascular Interventions
June 2013, Volume 6, Issue 3
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Introduction
    • Patient 1
    • Patient 2
    • Discussion
    • Disclosures
    • Footnotes
    • References
  • Figures & Tables
  • Supplemental Materials
  • Info & Metrics

Article Tools

  • Print
  • Citation Tools
    Renal Artery Stent Fracture in Patients With Fibromuscular Dysplasia
    Manjunath G. Raju, Christopher T. Bajzer, Daniel G. Clair, Esther S.H. Kim and Heather L. Gornik
    Circulation: Cardiovascular Interventions. 2013;6:e30-e31, originally published June 18, 2013
    https://doi.org/10.1161/CIRCINTERVENTIONS.113.000193

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Circulation: Cardiovascular Interventions.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Renal Artery Stent Fracture in Patients With Fibromuscular Dysplasia
    (Your Name) has sent you a message from Circulation: Cardiovascular Interventions
    (Your Name) thought you would like to see the Circulation: Cardiovascular Interventions web site.
  • Share on Social Media
    Renal Artery Stent Fracture in Patients With Fibromuscular Dysplasia
    Manjunath G. Raju, Christopher T. Bajzer, Daniel G. Clair, Esther S.H. Kim and Heather L. Gornik
    Circulation: Cardiovascular Interventions. 2013;6:e30-e31, originally published June 18, 2013
    https://doi.org/10.1161/CIRCINTERVENTIONS.113.000193
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Intervention, Surgery, Transplantation
    • Treatment

Circulation: Cardiovascular Interventions

  • About Circulation: Cardiovascular Interventions
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
200 Fifth Avenue, Suite 1020
Waltham, MA 02451 
email: circ@circulationjournal.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer
  • You're the Cure

Online Communities

  • AFib Support
  • Empowered to Serve
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2018 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured